We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
376
DELISTED
Exact Sciences
EXAS
| $6.7M | 0.06% |
+50,586
| New | +$6.12M |
|
377
Ball Corp
BALL
$16.4B
| $6.68M | 0.06% |
+71,746
| New | +$6.63M |
|
378
Labcorp
LH
$26.2B
| $6.67M | 0.06% |
+38,145
| New | +$6.59M |
|
379
IQVIA
IQV
$39.8B
| $6.67M | 0.06% |
37,205
-50,746
| -58% | -$8.55M |
|
380
Primerica
PRI
$9.62B
| $6.61M | 0.06% |
49,366
+39,734
| +413% | +$4.99M |
|
381
Idexx Laboratories
IDXX
$44.7B
| $6.6M | 0.06% |
13,195
-19,010
| -59% | -$8.51M |
|
382
Lennox International
LII
$14.5B
| $6.59M | 0.06% |
24,048
+1,054
| +5% | +$300K |
|
383
ACM Research
ACMR
$5.65B
| $6.59M | 0.06% |
243,177
-14,430
| -6% | -$369K |
|
384
Chewy
CHWY
$9.2B
| $6.56M | 0.06% |
+72,930
| New | +$5.32M |
|
385
Aptiv
APTV
$10.2B
| $6.49M | 0.05% |
49,834
+36,949
| +287% | +$4.1M |
|
386
Red Rock Resorts
RRR
$3.67B
| $6.49M | 0.05% |
259,129
+126,190
| +95% | +$2.69M |
|
387
Grand Canyon Education
LOPE
$3.79B
| $6.47M | 0.05% |
69,515
-36,942
| -35% | -$3.15M |
|
388
Hilton Worldwide
HLT
$72.2B
| $6.46M | 0.05% |
58,092
+304
| +0.5% | +$30.1K |
|
389
Petrobras
PBR
$115B
| $6.42M | 0.05% |
571,704
-431,100
| -43% | -$3.82M |
|
|
ZGNX
390
DELISTED
Zogenix, Inc.
ZGNX
| $6.42M | 0.05% |
321,053
-17,680
| -5% | -$361K |
|
391
Public Storage
PSA
$61.4B
| $6.42M | 0.05% |
+27,787
| New | +$6.37M |
|
392
Gogo Inc
GOGO
$377M
| $6.38M | 0.05% |
662,374
-46,867
| -7% | -$464K |
|
393
Insperity
NSP
$2.05B
| $6.38M | 0.05% |
78,337
-25,765
| -25% | -$2.12M |
|
394
Alliant Energy
LNT
$18.2B
| $6.38M | 0.05% |
+123,725
| New | +$6.65M |
|
395
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $6.36M | 0.05% |
165,125
+23,353
| +16% | +$873K |
|
396
Emcor
EME
$36.7B
| $6.3M | 0.05% |
68,942
-20,821
| -23% | -$1.67M |
|
397
Hanover Insurance
THG
$7.77B
| $6.29M | 0.05% |
53,829
-37,252
| -41% | -$4.02M |
|
398
Sabre
SABR
$892M
| $6.2M | 0.05% |
515,415
-1,029,326
| -67% | -$9.52M |
|
399
Itaú Unibanco
ITUB
$80.9B
| $6.15M | 0.05% |
+1,387,999
| New | +$5.19M |
|
400
AvalonBay Communities
AVB
$26.3B
| $6.14M | 0.05% |
38,279
-229,432
| -86% | -$36.5M |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.